|
|
Volumn 36, Issue SUPPL. 2, 1999, Pages 27-30
|
|
The future of endocrine treatment in early prostate cancer: Concluding remarks
|
|
Author keywords
Hormonal therapy; Prostate cancer; Quality of life
|
|
Indexed keywords
ANTIANDROGEN;
BICALUTAMIDE;
PROSTATE SPECIFIC ANTIGEN;
ADJUVANT THERAPY;
ANEMIA;
CANCER SCREENING;
CANCER STAGING;
CANCER SURVIVAL;
CASTRATION;
CLINICAL TRIAL;
CONFERENCE PAPER;
DISEASE COURSE;
EARLY DIAGNOSIS;
FUTUROLOGY;
GYNECOMASTIA;
HORMONAL THERAPY;
HUMAN;
MALE;
MUSCLE ATROPHY;
OSTEOPOROSIS;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
SEXUAL DYSFUNCTION;
TREATMENT PLANNING;
ANDROGEN ANTAGONISTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
QUALITY OF LIFE;
|
|
EID: 0032860022
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000052340 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (16)
|
